FERRISCAN R2-MRI ANALYSIS SYSTEM

Liver Iron Concentration Imaging Companion Diagnostic For Deferasirox

RESONANCE HEALTH ANALYSIS SERVICES PTY LTD

The following data is part of a De Novo classification by Resonance Health Analysis Services Pty Ltd with the FDA for Ferriscan R2-mri Analysis System.

Pre-market Notification Details

DeNovo IDDEN130012
Device Name:FERRISCAN R2-MRI ANALYSIS SYSTEM
ClassificationLiver Iron Concentration Imaging Companion Diagnostic For Deferasirox
Applicant RESONANCE HEALTH ANALYSIS SERVICES PTY LTD 3722 Ave. Sausalito Irvine,  CA  92606
ContactGreg Holland
Product CodePCS  
CFR Regulation Number892.1001 [🔎]
DecisionGranted (DENG)
510(k) Premarket NotificationK124065
Review Advisory BoardRadiology
Classification AdvisoryRadiology
TypeDirect
Date Received2013-01-02
Decision Date2013-01-23
FDA ReviewDecision Summary
Reclassification Order:Reclassification Order

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.